Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
AK ›
AKAFTREO
Trademark search for:
AKAFTREO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-07-10 — Application filed
2018-07-13 — Application filed
2018-07-14 — Application filed
2018-07-17 — Notice of design search code e-mailed
2018-07-18 — Assigned to examiner
2018-07-18 — Approved for pub - principal register
2018-08-01 — Notification of notice of publication e-mailed
2018-08-21 — Published for opposition
2018-08-21 — Official gazette publication confirmation e-mailed
2018-10-16 — Noa e-mailed - sou required from applicant
2019-04-15 — Sou teas extension received
2019-04-15 — Sou extension 1 filed
2019-04-15 — Sou extension 1 granted
2019-04-17 — Notice of approval of extension request e-mailed
2019-10-16 — Sou teas extension received
2019-10-16 — Sou extension 2 filed
2019-10-16 — Sou extension 2 granted
2019-10-18 — Notice of approval of extension request e-mailed
2020-04-08 — Sou teas extension received
2020-04-08 — Sou extension 3 filed
2020-04-08 — Sou extension 3 granted
2020-04-10 — Notice of approval of extension request e-mailed
2020-06-14 — Teas revoke/app/change addr of atty/dom rep received
2020-06-14 — Attorney/dom.rep.revoked and/or appointed
2020-06-14 — Teas change of correspondence received
2020-10-15 — Sou teas extension received
2020-10-15 — Sou extension 4 filed
2020-10-15 — Sou extension 4 granted
2020-10-17 — Notice of approval of extension request e-mailed
2021-04-16 — Sou teas extension received
2021-04-16 — Sou extension 5 filed
2021-04-30 — Case assigned to intent to use paralegal
2021-04-30 — Sou extension 5 granted
2021-05-01 — Notice of approval of extension request e-mailed
2021-11-22 — Application abandoned
2021-11-22 — Application abandoned
2021-11-22 — Final status recorded
Owner Information
Vertex Pharmaceuticals Incorporated
Boston , MA
Vertex Pharmaceuticals Incorporated
Boston , MA
Correspondent
Timothy H. Hiebert Womble Bond Dickinson (US) LLP 470 Atlantic Ave., Suite 600 Boston, MA 02210-2228 UNITED STATES
Filing Details
Filing Date:
2018-07-10
Status Date:
2021-11-22
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.